Stocks Health care CRL
NYSE · Health careCharles River Laboratories International, Inc. (CRL)
Charles River Laboratories International, Inc. brought in $4B of revenue over the twelve months to June 27, 2026, down 0.7% from a year earlier. It posted a net loss of $238.5M. Operating cash flow minus capital spending left $518.5M of free cash flow in fiscal 2025. At June 27, 2026 it held $192M in cash against $5.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
What Charles River Laboratories International, Inc. does
Charles River Laboratories International, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NYSE under the ticker CRL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4B | -$144.3M | -$2.91 | $518.5M |
| 2024 | $4B | $22.2M | $0.20 | $501.6M |
| 2023 | $4.1B | $474.6M | $9.22 | $365.4M |
| 2022 | $4B | $486.2M | $9.48 | $294.9M |
| 2021 | $3.5B | $391M | $7.60 | $532M |
| 2020 | $2.9B | $364.3M | $7.20 | $380M |
Latest SEC filings
What Charles River Laboratories International, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026
- September 8, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026Quarterly report 10-Q · period to June 27, 2026
- August 5, 2026
- May 11, 2026
- May 11, 2026
- May 7, 2026
- May 7, 2026Quarterly report 10-Q · period to March 28, 2026
- May 7, 2026
Questions about CRL
What does Charles River Laboratories International, Inc. do?
Charles River Laboratories International, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NYSE under the ticker CRL.
Is Charles River Laboratories International, Inc. profitable?
No. Over the twelve months to June 27, 2026 it reported a net loss of $238.5M on revenue of $4B.
How much revenue does Charles River Laboratories International, Inc. make?
Over the twelve months to June 27, 2026 Charles River Laboratories International, Inc. reported revenue of $4B. That is 0.7% less than a year earlier.
When did Charles River Laboratories International, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 27, 2026. Its newest filing of any kind is the investor disclosure from September 24, 2026.
Similar companies
Follow CRL
Get an email when Charles River Laboratories International, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CRL: get an email when it filesWhere the numbers come from
Financial figures are the values Charles River Laboratories International, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.